retatrutide dosing in clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied Phase 3 for metabolic health — targeting GLP-1, GIP retatrutide dosing clinical trials retatrutide

Qs next: The diverse functions of glutamine in metabolism, cell biology and cancer

Its rooted in what actually works

Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients

Compartmentalised acyl-CoA metabolism and roles in chromatin regulation

[Multiple acyl-CoA dehydrogenase deficiency (MADD): a curable cause of genetic muscular lipidosis]

In patients with Crohns disease (CD) and ulcerative colitis (UC), higher amounts of Escherichia coli have been observed pointing to the possibility that administration of PPIs would further induce these infections (Bruno et al